M.D., MS, MBE, Principal Researcher at the American Institutes for Research
Dr. Deverka conducts health policy studies at AIR, primarily in the area of personalized medicine with projects funded by NHGRI and PCORI. She is a recognized expert in the area of coverage and reimbursement for new genomic-based technologies and has worked collaboratively with stakeholders to recommend standards for a more predictable reimbursement pathway. Recently, she has analyzed data from a private payer coverage policy registry for NGS-based tests and led a study of policy barriers for NIPT. Dr. Deverka leads the public deliberation component of an NHGRI-funded grant to examine policy issues surrounding genomic data sharing in a medical information commons. Prior to working in the non-profit sector, she spent nearly 15 years in the pharmaceutical and PBM industries leading departments of outcomes research. She has a master’s degree in bioethics from the University of Pennsylvania and completed a policy fellowship at Duke University’s Institute for Genome Sciences and Policy.
Pursuing Clinical Utility for Multi-Gene Tests and Genome-Scale Testing
The current evidentiary framework for clinical practice guidelines and coverage decisions for genetic tests is built on an assessment of analytic and clinical validity as well as clinical utility. This talk will describe recent efforts by NHGRI, IOM and non-profit groups to expand the methods for evaluating the clinical utility of multi-gene tests.